Effect of Sodium and UF Profiling on Dialysis

Launched by ASSIUT UNIVERSITY · Jan 17, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how sodium and a treatment called UF profiling affect patients undergoing hemodialysis. The goal is to see if these methods can help improve patients' blood pressure stability during treatment, reduce weight gain between dialysis sessions, and lessen complications that might occur during dialysis.

To participate in this study, you would need to have end-stage renal disease and be on regular hemodialysis. Unfortunately, if you're not feeling stable during treatment or if you choose not to participate, you wouldn't be eligible. If you join the trial, you can expect to help researchers learn more about these treatments and potentially improve care for future dialysis patients. This study is still in the planning stages and has not started recruiting participants yet.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • End-stage renal disease patients.
• • Patients on regular hemodialysis
• Exclusion Criteria:
• • Patients who refuse to contribute in this study.
• • Hemodynamically unstable patients.